Affordable Cancer Treatment, Oncology Treatment

Total Views - 27

SENIOR DIRECTOR & HOD RADIATION ONCOLOGY | at Fortis Gurgaon
EXPERTISE: Intensity Modulated Radiotherapy [IMRT), Image guided radiotherapy [IGRT), Stereotactic Radiosurgery, Stereotactic radiotherapy and Intra operative Brachytherapy
QUALIFICATION: MBBS and MD (Radiotherapy & Oncology)
PRACTICING AT: Fortis Gurgaon

TRAINED AT: PGIMER, Chandigarh
PUBLICATIONS: Numerous papers published in journals of national and international repute, to his credit.
REGISTRATION: 2277 Delhi Medical Council, 2000
EDUCATION:
MBBS, MD (Radiotherapy & Oncology)

ANY SUCCESS STORY:
He was awarded commonwealth fellowship and worked at The Middlesex Hospital Medical School, London and was also awarded Nargis Dutt Foundation Fellowship at the New York Hospital Medical Centre of Queens, New York, affiliated to Cornell University
Memberships

Member, Association of Radiation Oncologists of India
Member, Radiation Research Society (RRS), USA
Member, Americal Society for Therapeutic Oncology (ASTRO)
Empanel led by WHO & UNO as a recommended doctor
Member Editorial Board JCRT

DESCRIPTION:
Dr. A.K. Anand is a renowned Oncologist of India. An MBBS and MD (Radiotherapy & Oncology), he has a vast experience in his field of expertise. He has held various posts including his present position as the Director – Department of Radiation Oncologist – Max Hospital, Saket, Senior Consultant and Coordinator-Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi; Senior Consultant -Department of Radiation Oncologist, Batra Hospital. He has also been an active member of Association of Radiation Oncologists, India; Radiation Research Society, USA; American Society for Therapeutic Oncologist, USA. Dr. Anand has also won many awards and accreditations. He has been empanelled by the World Health Organization and UNO as a recommended doctor. Currently, he is working as a Director, Radiation Oncologist at Max Super Specialty Hospital, New Delhi.

India’s Affordable cancer medicines